Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page
- Check2 days agoChange DetectedA new Revision: v3.5.4 entry was added and the previous Revision: v3.5.3 entry was removed, updating the page to reflect the latest release version.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision tag was updated from v3.5.2 to v3.5.3, signaling an updated release of the page's documentation/assets. This is an administrative update and does not reflect changes to study content or data.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.2 is now displayed on the page, replacing the previous v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedUpdated two location entries from Napoli, Italy, 80131 and 87100 to Naples, Italy, 80131 and 87100.SummaryDifference0.1%

- Check59 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.